• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib: A 32-week open-label extension study with optional narrow-band ultraviolet B.

作者信息

Joshipura Deep, Alomran Abdulaziz, Zancanaro Pedro, Rosmarin David

机构信息

Department of Dermatology, Tufts Medical Center, Boston, Massachusetts.

Department of Dermatology, Tufts Medical Center, Boston, Massachusetts.

出版信息

J Am Acad Dermatol. 2018 Jun;78(6):1205-1207.e1. doi: 10.1016/j.jaad.2018.02.023. Epub 2018 Feb 10.

DOI:10.1016/j.jaad.2018.02.023
PMID:29438765
Abstract
摘要

相似文献

1
Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib: A 32-week open-label extension study with optional narrow-band ultraviolet B.外用Janus激酶抑制剂芦可替尼治疗白癜风：一项为期32周的开放标签扩展研究，可选择窄谱中波紫外线照射。
J Am Acad Dermatol. 2018 Jun;78(6):1205-1207.e1. doi: 10.1016/j.jaad.2018.02.023. Epub 2018 Feb 10.
2
Treatment of vitiligo with topical 15% lactic acid solution in combination with ultra violet-A.外用15%乳酸溶液联合紫外线A治疗白癜风。
Saudi Med J. 2005 Dec;26(12):2011; author reply 2011.
3
The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.1%吡美莫司乳膏联合窄谱中波紫外线治疗白癜风的疗效：一项双盲、安慰剂对照临床试验
J Dermatolog Treat. 2009;20(1):14-8. doi: 10.1080/09546630802155057.
4
Efficacy and tolerability of combined treatment with NB-UVB and topical tacrolimus versus NB-UVB alone in patients with vitiligo vulgaris: a randomized intra-individual open comparative trial.窄谱中波紫外线（NB-UVB）与外用他克莫司联合治疗与单用NB-UVB治疗寻常型白癜风患者的疗效和耐受性：一项随机个体内开放对照试验。
Indian J Dermatol Venereol Leprol. 2013 Jul-Aug;79(4):525-7. doi: 10.4103/0378-6323.113091.
5
Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib.用局部 Janus 激酶抑制剂芦可替尼治疗白癜风。
J Am Acad Dermatol. 2017 Jun;76(6):1054-1060.e1. doi: 10.1016/j.jaad.2017.02.049. Epub 2017 Apr 5.
6
A prospective observational study of oral abrocitinib and narrow-band ultraviolet-B in refractory progressive vitiligo.口服阿布昔替尼与窄谱紫外线B治疗难治性进展期白癜风的前瞻性观察研究
J Am Acad Dermatol. 2024 Sep;91(3):590-592. doi: 10.1016/j.jaad.2024.05.078. Epub 2024 Jun 6.
7
Comparison of the efficacy of narrow band ultraviolet B and narrow band ultraviolet B plus topical catalase-superoxide dismutase treatment in vitiligo patients.窄谱中波紫外线与窄谱中波紫外线联合外用过氧化氢酶-超氧化物歧化酶治疗白癜风患者的疗效比较
Eur J Dermatol. 2009 Jul-Aug;19(4):341-4. doi: 10.1684/ejd.2009.0699. Epub 2009 May 25.
8
Treatment of vitiligo with broadband ultraviolet B and vitamins.采用宽带紫外线B和维生素治疗白癜风。
Int J Dermatol. 2006 Jan;45(1):63-5. doi: 10.1111/j.1365-4632.2005.02447.x.
9
Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study.四氢姜黄素乳膏联合靶向窄谱中波紫外线光疗治疗白癜风：一项初步随机对照研究。
Photomed Laser Surg. 2010 Oct;28(5):679-84. doi: 10.1089/pho.2009.2637.
10
Treatment of vitiligo vulgaris with narrow band UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12.用窄谱中波紫外线（311nm）治疗寻常型白癜风一年及添加叶酸和维生素B12的效果
Acta Derm Venereol. 2002;82(5):369-72. doi: 10.1080/000155502320624113.

引用本文的文献

1
Efficacy and Safety of JAK Inhibitors in the Management of Vitiligo: A Systematic Review and Meta-analysis.JAK抑制剂治疗白癜风的疗效与安全性：一项系统评价和Meta分析
Dermatol Ther (Heidelb). 2025 May 7. doi: 10.1007/s13555-025-01397-z.
2
Emerging Therapeutic Innovations for Vitiligo Treatment.白癜风治疗的新兴治疗创新
Curr Issues Mol Biol. 2025 Mar 14;47(3):191. doi: 10.3390/cimb47030191.
3
Dietary Interventions, Supplements, and Plant-Derived Compounds for Adjunct Vitiligo Management: A Review of the Literature.用于白癜风辅助治疗的饮食干预、补充剂及植物源化合物：文献综述
Nutrients. 2025 Jan 20;17(2):357. doi: 10.3390/nu17020357.
4
Short-term efficacy and safety of upadacitinib combined with 308 excimer light versus upadacitinib alone and 308 excimer light alone in patients with progressing facial vitiligo.乌帕替尼联合308准分子光与单独使用乌帕替尼及单独使用308准分子光治疗进展期面部白癜风患者的短期疗效和安全性比较
Arch Dermatol Res. 2025 Jan 16;317(1):252. doi: 10.1007/s00403-024-03717-3.
5
Short-term (24 weeks) treatment efficacy and safety of ruxolitinib cream in participants with vitiligo: a systematic review and meta-analysis.短期（24 周）治疗白癜风患者鲁索替尼乳膏的疗效和安全性：系统评价和荟萃分析。
Syst Rev. 2024 Oct 2;13(1):250. doi: 10.1186/s13643-024-02653-7.
6
[Janus kinase inhibitors for skin disorders].用于皮肤疾病的 Janus 激酶抑制剂
Dermatologie (Heidelb). 2024 Oct;75(10):781-790. doi: 10.1007/s00105-024-05406-8. Epub 2024 Aug 30.
7
A meta-analysis of therapeutic trials of topical ruxolitinib cream for the treatment of vitiligo: therapeutic efficacy, safety, and implications for therapeutic practice.一项外用鲁索替尼乳膏治疗白癜风的治疗试验的荟萃分析：疗效、安全性和对治疗实践的影响。
Arch Dermatol Res. 2024 Aug 12;316(8):518. doi: 10.1007/s00403-024-03267-8.
8
Identifying the genetic association between common rheumatic diseases and vitiligo.鉴定常见风湿性疾病与白癜风之间的遗传关联。
Skin Res Technol. 2024 Jul;30(7):e13846. doi: 10.1111/srt.13846.
9
Vitiligo: Pathogenesis and New and Emerging Treatments.白癜风：发病机制与新型及新兴治疗方法。
Int J Mol Sci. 2023 Dec 9;24(24):17306. doi: 10.3390/ijms242417306.
10
Updates on Potential Therapeutic Approaches for Vitiligo: Janus Kinase Inhibitors and Biologics.白癜风潜在治疗方法的最新进展：Janus激酶抑制剂和生物制剂。
J Clin Med. 2023 Dec 4;12(23):7486. doi: 10.3390/jcm12237486.